The risk of acute disseminated encephalomyelitis (ADEM) following covid-19 vaccination in England: A self-controlled case-series analysis
ABSTRACTAcute disseminated encephalomyelitis (ADEM) has been identified as an Adverse Event of Special Interest in the COVID-19 vaccine programme due to its long-standing temporal association with a wide range of other vaccines. Case reports of ADEM shortly following COVID−19 vaccination have now be...
Hoofdauteurs: | Julia Stowe, Jamie Lopez-Bernal, Nick Andrews |
---|---|
Formaat: | Artikel |
Taal: | English |
Gepubliceerd in: |
Taylor & Francis Group
2024-12-01
|
Reeks: | Human Vaccines & Immunotherapeutics |
Onderwerpen: | |
Online toegang: | https://www.tandfonline.com/doi/10.1080/21645515.2024.2311969 |
Gelijkaardige items
-
Clinical features and outcome of acute disseminated encephalomyelitis (ADEM): An outlook from South India
door: Maramattom Boby, et al.
Gepubliceerd in: (2006-01-01) -
Acute Disseminated Encephalomyelitis: A Review of Eleven Cases in Childhood in North of Iran
door: Ali Nikkhah, et al.
Gepubliceerd in: (2016-01-01) -
An Interesting Case Of Acute Disseminated Encephalomyelitis
door: Satish Kumar, et al.
Gepubliceerd in: (2008-04-01) -
The Epidemiologic and Demographic Characteristics and Clinical Findings in Patients with Acute Disseminated Encephalomyelitis (ADEM) Referred to Alzahra Hospital, Isfahan, Iran, During 10 Years (2003-2013)
door: Masoud Etemadifar, et al.
Gepubliceerd in: (2015-09-01) -
Whole exome sequencing in a child with acute disseminated encephalomyelitis, optic neuritis, and periodic fever syndrome: a case report
door: Pablo A. Ledesma, et al.
Gepubliceerd in: (2019-12-01)